期刊文献+

全身炎症反应和心律失常风险相关性研究进展 被引量:6

Systemic inflammation and arrhythmic risk
原文传递
导出
摘要 类风湿性关节炎中超过50%的患者死于心血管疾病,其心源性猝死的发生率是非类风湿性关节炎患者的2倍,且更易发生恶性室性心律失常。类风湿性关节炎致心律失常的机制可能是全身慢性炎症反应激活后,通过加速缺血性心脏病和充血性心力衰竭的发生发展,影响心脏电生理,从而促使心律失常的发生。因此,通过严格控制类风湿性关节炎疾病活动性以降低炎症负担,可能是减少类风湿性关节炎患者心律失常发生风险最有效的干预措施。 More than 50% Rheumatoid arthritis patients die from cardiovascular disease,and the incidence of sudden cardiac death for rheumatoid arthritis is 2times than non-RA patients.Rheumatoid arthritis is more likely to undergo malignant ventricular arrhythmia.Arrhythmia caused by rheumatoid arthritis might be due to the mechanism of systemic chronic inflammatory response activation,by accelerating the development of ischemic heart disease and congestive heart failure,affecting cardiac electrophysiology,prompting the occurrence of arrhythmia.Therefore,controlling the activation of rheumatoid arthritis strictly by reducing the burden of inflammation,could reduce the risk of arrhythmia for rheumatoid arthritis patients.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2017年第8期802-804,共3页 Journal of Clinical Cardiology
基金 国家自然科学基金重点项目(No:81530013)
关键词 类风湿性关节炎 全身炎症反应 心律失常 rheumatoid arthritis systemic inflammation arrhythmias
  • 相关文献

参考文献2

二级参考文献22

  • 1FOX K A,ANDERSON F A JR, DABBOUS O H, et al. Intervention in acute coronary syndromes., do pa- tients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coro- nary Events (GRACE)[J]. Heart, 2007, 93 : 177-- 182.
  • 2KANEKO H, ANZAI T, NAITO K, et al. Role of ischemic preconditioning and inflammatory response in the development of malignant ventricular arrhythmias after reperfused ST-elvation myocardial infarction[J]. J Card Fail., 2009, 15: 775--781.
  • 3PEPYS M B, HIRSCHFIELD G M, TENNENT GA, et al. Targeting C-reactive protein for the treat- ment of cardiovascular disease[J]. Nature, 2006, 440:1217--1221.
  • 4CHUNG M K, MARTIN D O, SPRECHER D, et al. C-reactive protein elevation in patients with atrial arrhythmias; inflammatory mechanisms and persist- ence of atrial fibrillation [J]. Circulation, 2001,104: 2886--2891.
  • 5VYAS A K, GUO H, MOSS A J, et al. Reduction in ventricular tachyarrhythmias with statins in the MAD- IT II trial [J]. J Am Coll Cardiol, 2006, 47:769-- 773.
  • 6MITCHELL L B, POWELL J L, GILLIS A M, et al. Are lipid-lowering drugs also anti-arrhythmic drugs[J]. J Am Coil Cardiol, 2003, 42: 81--87.
  • 7ABREU C D, NUNES MDO C, BARBOSA M M, et al. Venticular dyssynchrony and increased BNP levels in right ventricular apical pacing[J]. Arq Bras Cardi- ol, 2011, 97: 156--162.
  • 8BLANGY H, SADOUL N, DOUSSET B, et al. Ser- um BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients af- ter myocardial infarction[J]. Europace, 2007, 9:724 --729.
  • 9SANJUAN R, BLASCO M L, MARTINEZ-MAI- CAS H, et al. Acute myocardial infarction: high risk ventricular tachyarrhythmias and admission glucose level in patients with and without diabetes mellitus [J] Curr Diabetes Rev, 2011, 7:126--134.
  • 10MARFELLA R, NAPPO F, DE ANGELIS L, et al. The effect of acute hyperglycaemia on QTc duration in healthy man[J]. Diabetologia, 2000,43 : 571 -- 575.

共引文献27

同被引文献90

引证文献6

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部